Abstract:Hongfeng Wang, 1, * Yuna Shang, 2, * Xiaoniao Chen, 3 Zhongyan Wang, 2 Dashuai Zhu, 4 Yue Liu, 4 Chuyue Zhang, 1 Pu Chen, 1 Jie Wu, 1 Lingling Wu, 1 Deling Kong, 2 Zhimou Yang, 2 Zongjin Li, 4 Xiangmei Chen 1 1 Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases, Beijing 100039, People's Republic of China; 2 State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, Tianjin 300071, People's Republic of China; 3 Department of Ophthalmology, Chinese PLA General Hospital, Beijing 100039, People's Republic of China; 4 Department of Pathophysiology, Nankai University School of Medicine, Tianjin, 300071, People's Republic of China *These authors contributed equally to this work Correspondence: Xiangmei Chen Chinese PLA General Hospital, Beijing 100039, People's Republic of China Email xmchen301@126.com Zhimou Yang Nankai University, Tianjin 300071, People's Republic of China Email yangzm@nankai.edu.cn Purpose: By providing a stem cell microenvironment with particular bioactive constituents in vivo, synthetic biomaterials have been progressively successful in stem cell-based tissue regeneration by enhancing the engraftment and survival of transplanted cells. Designs with bioactive motifs to influence cell behavior and with D-form amino acids to modulate scaffold stability may be critical for the development and optimization of self-assembling biomimetic hydrogel scaffolds for stem cell therapy. Materials and Methods: In this study, we linked naphthalene (Nap) covalently to a short D-form peptide (Nap- D F D FG) and the C domain of insulin-like growth factor-1 (IGF-1C) as a functional hydrogel-based scaffolds, and we hypothesized that this hydrogel could enhance the therapeutic efficiency of human placenta-derived mesenchymal stem cells (hP-MSCs) in a murine acute kidney injury (AKI) model. Results: The self-assembling peptide was constrained into a classical β-sheet structure and showed hydrogel properties. Our results revealed that this hydrogel exhibited increased affinity for IGF-1 receptor. Furthermore, cotransplantation of the β-IGF-1C hydrogel and hP-MSCs contributed to endogenous regeneration post-injury and boosted angiogenesis in a murine AKI model, leading to recovery of renal function. Conclusion: This hydrogel could provide a favorable niche for hP-MSCs and thereby rescue renal function in an AKI model by promoting cell survival and angiogenesis. In conclusion, by covalently linking the desired functional groups to D-form peptides to create functional hydrogels, self-assembling β-sheet peptide hydrogels may serve as a promising platform for tissue-engineering and stem cell therapy. Keywords: self-assembly, β-sheet, hydrogel, D-form peptide, C domain of insulin-like growth factor, IGF-1C, mesenchymal stem cells, MSCs, acute kidney injure, AKI

Co‐Delivery of Anti‐Inflammatory and Proliferative Agents by Injectable Hydrogel to Promote Tissue Repair after Acute Kidney Injury

A self-assembling peptide hydrogel-based drug co-delivery platform to improve tissue repair after ischemia-reperfusion injury

A Biomimetic Double Network Hydrogel Ameliorates Renal Fibrosis and Promotes Renal Regeneration

Rebuilding Postinfarcted Cardiac Functions by Injecting TIIA@PDA Nanoparticle-Cross-linked ROS-Sensitive Hydrogels

Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy

Hydrogel-Mediated Local Delivery of Induced Nephron Progenitor Cell-Sourced Molecules as a Cell-Free Approach for Acute Kidney Injury

Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applications.

An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis

Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair.

Sustained Release of Hepatocyte Growth Factor by Cationic Self-Assembling Peptide/heparin Hybrid Hydrogel Improves Β-Cell Survival and Function Through Modulating Inflammatory Response

A supramolecular hydrogel based on the combination of YIGSR and RGD enhances mesenchymal stem cells paracrine function via integrin α2β1 and PI3K/AKT signaling pathway for acute kidney injury therapy

Artificial Kidney Capsule Packed with Mesenchymal Stem Cell-Laden Hydrogel for the Treatment of Rhabdomyolysis-Induced Acute Kidney Injury.

An Injectable, Wound-Adapting, Self-Healing Hydrogel for Fibroblast Growth Factor 2 Delivery System in Tissue Repair Applications.

Supramolecular Nanofibers Containing Arginine-Glycine-Aspartate (RGD) Peptides Boost Therapeutic Efficacy of Extracellular Vesicles in Kidney Repair

1,2-Bis(2-aminophenoxy)ethane- N, N, N', N'-tetraacetic Acid Acetoxymethyl Ester Loaded Reactive Oxygen Species Responsive Hyaluronic Acid-Bilirubin Nanoparticles for Acute Kidney Injury Therapy via Alleviating Calcium Overload Mediated Endoplasmic Reticulum Stress

3D hypoxia-mimicking and anti-synechia hydrogel enabling promoted neovascularization for renal injury repair and regeneration

Heparin-conjugated injectable hydrogels with sustained releasing capability for promotion of H-type vessels formation and rat femoral bone defects repair

Multifunctional Integrally-Medicalized Hydrogel System with Internal Synergy for Efficient Tissue Regeneration

Injectable Extracellular Vesicle-Released Self-Assembling Peptide Nanofiber Hydrogel As an Enhanced Cell-Free Therapy for Tissue Regeneration.

Innovative hydrogel-based therapies for ischemia-reperfusion injury: bridging the gap between pathophysiology and treatment

Thermosensitive hydrogel for cartilage regeneration via synergistic delivery of SDF-1α like polypeptides and kartogenin